Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by Pinksheepon Mar 12, 2015 11:06pm
245 Views
Post# 23516757

RE:RE:Let's talk seriously!

RE:RE:Let's talk seriously!
Johnny881 wrote: There are problems with your math. For instance, if our generics bring in $12,500 per store in revenue to us per month and our margin is 70%, our cost of goods is only $3750 per month per store. That's one problem with your scenario. The other is you negate to use any credit terms on our purchase of goods. Surely sales revenue would be collected monthly also and with such a healthy margin that would easily facilitate the repurchasing of product and allow for rapid growth in sales ability.


Wow! No time to lose anymore, 3 times $3750 is what. It ain't because you collect your gain every month that you don't need 3 months of supply in the back store of each pharma. That is what you call a start up.... That is why any company has issues while they start. Would you be took seriously if 45 of your 150 pharma that you furnish would have lack of inventory. Never forget it's coming by boat from the East... After the ... Start up, you roll with regularly supplying... But you always keep over 2 months of inventory....
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse